Skip to content

Deciphering the pathogenesis of skin disorders driven by genetic alterations via multi-omics analysis

Deciphering the pathogenesis of skin disorders driven by genetic alterations via multi-omics analysis - Deciphering the pathogenesis of skin disorders driven by genetic alterations via multi-omics analysis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000059483
Enrollment
3600
Registered
2025-10-21
Start date
2023-04-21
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

genodermatoses

Interventions

None listed

Sponsors

Kobe University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients (and their relatives) diagnosed with any of the following conditions that manifest with symptoms involving the skin, including cutaneous adnexa (nails, hair, teeth) and mucosa (e.g., lips, oral cavity): (i) monogenic disorders; (ii) conditions for which a genetic background/predisposition is scientifically considered likely to contribute to disease onset; (iii) conditions for which acquired (somatic) genetic changes are scientifically considered likely to contribute to disease onset; (iv) undiagnosed disorders with cutaneous manifestations in which a genetic predisposition is inferred but the phenotype does not match any known disease.

Exclusion criteria

Exclusion criteria: (1) Patients with dementia or psychiatric disorders requiring treatment, or patients in a comatose state. (2) Patients whom the principal investigator judges to be unsuitable for inclusion in this study.

Design outcomes

Primary

MeasureTime frame
Identification of genetic alterations underlying skin diseases.

Countries

Japan

Contacts

Public ContactAi Yoshioka

Kobe University Graduate School of Medicine

aiichi39@med.kobe-u.ac.jp078-382-5111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026